AR106699A2 - Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso - Google Patents

Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso

Info

Publication number
AR106699A2
AR106699A2 ARP160103488A ARP160103488A AR106699A2 AR 106699 A2 AR106699 A2 AR 106699A2 AR P160103488 A ARP160103488 A AR P160103488A AR P160103488 A ARP160103488 A AR P160103488A AR 106699 A2 AR106699 A2 AR 106699A2
Authority
AR
Argentina
Prior art keywords
compositions
manufacture
contain
active compounds
pharmaceutically active
Prior art date
Application number
ARP160103488A
Other languages
English (en)
Inventor
John Toft Alexis
Peter Dr Rhodes Nigel
Sydney Dr Newton Maurice
Original Assignee
Cytochroma Dev Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytochroma Dev Inc filed Critical Cytochroma Dev Inc
Publication of AR106699A2 publication Critical patent/AR106699A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Una sustancia para uso como medicamento, que comprende un compuesto metálico sólido mixto de fórmula (1): MII₁₋ₐMIIIₐOᵇAⁿ⁻ᶜ·zH₂O (1) donde MII es al menos un metal bivalente; MIII es al menos un metal trivalente; Aⁿ⁻ es al menos un anión n-valente; 2 + a = 2b + Scn y Scn < 0.9a.
ARP160103488A 2005-02-10 2016-11-15 Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso AR106699A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0502787.5A GB0502787D0 (en) 2005-02-10 2005-02-10 Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use

Publications (1)

Publication Number Publication Date
AR106699A2 true AR106699A2 (es) 2018-02-07

Family

ID=34356109

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060100490A AR053678A1 (es) 2005-02-10 2006-02-10 Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso
ARP160103488A AR106699A2 (es) 2005-02-10 2016-11-15 Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP060100490A AR053678A1 (es) 2005-02-10 2006-02-10 Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso

Country Status (20)

Country Link
US (2) US20080206358A1 (es)
EP (2) EP1850859B1 (es)
JP (2) JP5328157B2 (es)
KR (3) KR20140066756A (es)
CN (2) CN101115490B (es)
AR (2) AR053678A1 (es)
AU (1) AU2006213922B2 (es)
BR (1) BRPI0606923B1 (es)
CA (1) CA2597124C (es)
ES (1) ES2599152T3 (es)
GB (1) GB0502787D0 (es)
IL (1) IL184448A (es)
MX (1) MX2007009688A (es)
MY (1) MY150070A (es)
NO (2) NO341846B1 (es)
NZ (1) NZ556600A (es)
RU (1) RU2420297C2 (es)
TW (1) TWI461201B (es)
WO (1) WO2006085079A2 (es)
ZA (1) ZA200706160B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) * 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
GB201005931D0 (en) 2010-04-09 2010-05-26 Isis Innovation Immune modulation
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
EA202191134A1 (ru) 2018-10-25 2021-07-13 Эйрджен Фарма Лтд. Способы лечения смешанными металлосодержащими соединениями
RU2758671C1 (ru) * 2020-12-08 2021-11-01 Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) СПОСОБ ПОЛУЧЕНИЯ НАНОСТРУКТУРНЫХ ДВОЙНЫХ ГИДРОКСИДОВ НА ОСНОВЕ АЛЮМИНИЯ И ЩЕЛОЧНОЗЕМЕЛЬНЫХ МЕТАЛЛОВ, ТАКИХ КАК МАГНИЙ ИЛИ КАЛЬЦИЙ, ОБЛАДАЮЩИХ СВОЙСТВОМ ПОВЫШАТЬ pH КЛЕТОЧНОЙ СРЕДЫ, И НАНОСТРУКТУРЫ, ПОЛУЧЕННЫЕ ДАННЫМ СПОСОБОМ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838930C2 (de) * 1978-09-07 1980-07-03 Chemische Werke Huels Ag, 4370 Marl Wäßriges Behandlungsmittel für Holz und Holzwerkstoffe und dessen Verwendung
US4514389A (en) * 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US4566986A (en) * 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
US5153156A (en) * 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
US5246899A (en) * 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
NL9201907A (nl) * 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20040247696A1 (en) * 2001-07-05 2004-12-09 Antelman Marvin S. Methods of using electron active compounds for managing conditions afflicting mammals
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
JP4348426B2 (ja) 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
WO2005027876A1 (en) * 2003-08-28 2005-03-31 Ranbaxy Laboratories Limited Pharmaceutical compositions of benzimidazole and processes for their preparation
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate

Also Published As

Publication number Publication date
WO2006085079A3 (en) 2006-12-14
CN101115490A (zh) 2008-01-30
RU2420297C2 (ru) 2011-06-10
IL184448A0 (en) 2007-10-31
MY150070A (en) 2013-11-29
US20120093943A1 (en) 2012-04-19
NZ556600A (en) 2010-02-26
JP5328157B2 (ja) 2013-10-30
TWI461201B (zh) 2014-11-21
JP2008530065A (ja) 2008-08-07
AU2006213922A1 (en) 2006-08-17
CA2597124A1 (en) 2006-08-17
NO20074504L (no) 2007-11-12
NO20171769A1 (no) 2007-11-12
KR20070082918A (ko) 2007-08-22
EP1850859B1 (en) 2016-07-20
CN101115490B (zh) 2015-12-09
AR053678A1 (es) 2007-05-16
AU2006213922B2 (en) 2011-09-29
BRPI0606923B1 (pt) 2019-06-18
US20080206358A1 (en) 2008-08-28
ZA200706160B (en) 2009-02-25
KR101491531B1 (ko) 2015-03-09
IL184448A (en) 2014-12-31
CN105412150A (zh) 2016-03-23
MX2007009688A (es) 2008-01-22
EP1850859A2 (en) 2007-11-07
EP3120855A1 (en) 2017-01-25
KR20130121186A (ko) 2013-11-05
ES2599152T3 (es) 2017-01-31
AU2006213922A2 (en) 2006-08-17
TW200640476A (en) 2006-12-01
GB0502787D0 (en) 2005-03-16
BRPI0606923A2 (pt) 2009-12-01
KR20140066756A (ko) 2014-06-02
JP2013209401A (ja) 2013-10-10
RU2007133720A (ru) 2009-03-20
CN105412150B (zh) 2019-05-17
CA2597124C (en) 2015-11-24
WO2006085079A2 (en) 2006-08-17
NO341846B1 (no) 2018-02-05

Similar Documents

Publication Publication Date Title
AR106699A2 (es) Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso
BRPI0508540A8 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
BRPI0607796A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparação e uso do mesmo, e, composição farmacêutica
CL2011000504A1 (es) Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer.
AR047277A1 (es) Mezclas insecticidas sinergicas
NI201100048A (es) Aminotriazolopiridinas y su uso como inhibidores de la cinasa.
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
UY29410A1 (es) Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones.
BRPI0518781A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, e, uso de um composto
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
ECSP056220A (es) Nuevos compuestos 2-piridiniletilbenzamida
BRPI0506760A (pt) derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina como inibidores de igf-ir
UY30610A1 (es) Moduladores de mglur5
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
CR9268A (es) Nuevo derivado de diazabiciclononeno
UY29069A1 (es) Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia

Legal Events

Date Code Title Description
FB Suspension of granting procedure